New Research Profiles the Site Coordinator’s Role in Clinical Trials Success

Informing the Drug Development and Commercialization Industry

CARY, N.C.--(BUSINESS WIRE)-- Industry Standard Research (ISR) today announced the launch of a new and substantial research report titled “The Voice of the Site Coordinator.” This report presents data and analysis from 124 interviews with Study / Site Coordinators from the US, Europe, Latin America, and Asia.

“Most professionals in the drug development community intuitively understand that on-site coordinators play a role in managing clinical trials on behalf of trial sponsors and CROs. But data from several of our reports suggest that the importance of coordinators’ contributions to trial success may be underestimated,” explained Kevin Olson, CEO, ISR. Olson went on to state: “Most of the energy that sponsors and CROs place on a site tends to be directed at engaging the Investigators themselves. While the investigator is an undeniably important piece of the puzzle, our data suggest that directly engaging a site’s coordinator is likely to yield both faster recruitment and higher quality data.”

The report provides a detailed analysis of coordinators’ responsibilities; coordinators’ critical perspectives on improving the accuracy of feasibility estimates; and their insights into current patient recruitment practices and how to meaningfully improve them. The report even profiles sites’ uses of – and preferences for – different eDC and ePRO technologies.

Kevin Olson, CEO of Industry Standard Research, further explains:

“Drug development professionals are forever looking for ways to strengthen their partnerships with sites, and for good reason. “The Voice of the Site Coordinator” report provides a rigorous and insightful account of just how to do that. Site Coordinators told us, in detail, the type of relationships they want with sponsors and CROs, the mechanisms of communications they value, and the successes and short-comings of current processes. We believe that everything in this report can be put into immediate action.”

About Industry Standard Research

Industry Standard Research is the premier, full service market research service provider to the pharma and pharma services industries. With over a decade of experience in the industry, ISR delivers an unmatched level of domain expertise. For more information about our industry and custom research offerings, please visit the company’s Web site at www.ISRreports.com or email [email protected].



CONTACT:

Industry Standard Research
Kevin Olson, 919-301-0106
[email protected]

KEYWORDS:   United States  North America  North Carolina

INDUSTRY KEYWORDS:   Technology  Data Management  Health  Biotechnology  Clinical Trials  Pharmaceutical  Other Health  Research  Other Science  Science

MEDIA:

Logo
 Logo

Suggested Articles

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.

Johns Hopkins researchers developed a biodegradable polymer to transport large therapies into cells—including genes and even CRISPR.

UCB’s bispecific antibody recently beat Johnson & Johnson’s Stelara at clearing psoriasis symptoms, and now it has bested AbbVie’s Humira, too.